Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
CO-DAFALGAN Brausetabl 500/30mg 16 Stk
Drug
Co-Dafalgan, Brausetabletten
Analgetikum
01.01.2. – combined antipyretic analgesics
HAM – Human medicine
BRAT – Effervescent tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
12/3/1986
12/31/9999
Dosage strength
Co-Dafalgan, Brausetabletten
Analgetikum
01
Z – approved
Package
7680473530254
No information made available
A/R – Authorised / referenced
16 tablet(s)
025
Z – approved
Declaration
Component
500 mg paracetamolum
30 mg codeini phosphas hemihydricus
30 mg codeini phosphas hemihydricus
natrii hydrogenocarbonas
natrii carbonas
acidum citricum
natrii docusas
povidonum
aromatica
300 mg sorbitolum
30 mg aspartamum
58.5 mg E 211
384.7 mg natrium
natrii carbonas
acidum citricum
natrii docusas
povidonum
aromatica
300 mg sorbitolum
30 mg aspartamum
58.5 mg E 211
384.7 mg natrium
Spezialitätenliste***
SL
-
-
11.70
None
No
10%
No
Authorisation holder
7601001410169
UPSA Switzerland AG
Bahnhofstrasse 29
6300 Zug (ZG)
Bahnhofstrasse 29
6300 Zug (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.